161 related articles for article (PubMed ID: 3284824)
1. Both N-ras and c-myc are activated in the SHAC human stomach fibrosarcoma cell line.
Andeol Y; Nardeux PC; Daya-Grosjean L; Brison O; Cebrian J; Suarez H
Int J Cancer; 1988 May; 41(5):732-7. PubMed ID: 3284824
[TBL] [Abstract][Full Text] [Related]
2. A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line.
Nardeux PC; Daya-Grosjean L; Landin RM; Andéol Y; Suàrez HG
Biochem Biophys Res Commun; 1987 Jul; 146(2):395-402. PubMed ID: 3476115
[TBL] [Abstract][Full Text] [Related]
3. Ki-ras activation and expression in transformed mouse lung cell lines.
Pan YH; Nuzum EO; Hanson LA; Beer DG
Mol Carcinog; 1990; 3(5):279-86. PubMed ID: 2244960
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
5. Activation of N-ras induced by ultraviolet irradiation in vitro.
Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
[TBL] [Abstract][Full Text] [Related]
6. Cotransfection of plasmids with ras and myc oncogenes to diploid cells derived from rodent fetuses: alteration of neoplastic transformation frequency depending on the gestation period.
Yagi T; Sasayama S; Sasai H; Kakunaga T
Mol Carcinog; 1989; 1(4):222-8. PubMed ID: 2675900
[TBL] [Abstract][Full Text] [Related]
7. The N-ras oncogene is activated in a human medulloblastoma cell line.
Fults D; Maness PF; Nakamura Y; White R
Brain Res; 1989 Dec; 503(2):281-7. PubMed ID: 2691018
[TBL] [Abstract][Full Text] [Related]
8. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
[TBL] [Abstract][Full Text] [Related]
9. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells.
Paterson H; Reeves B; Brown R; Hall A; Furth M; Bos J; Jones P; Marshall C
Cell; 1987 Dec; 51(5):803-12. PubMed ID: 3315232
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.
You M; Candrian U; Maronpot RR; Stoner GD; Anderson MW
Proc Natl Acad Sci U S A; 1989 May; 86(9):3070-4. PubMed ID: 2654935
[TBL] [Abstract][Full Text] [Related]
11. Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.
Tadokoro K; Ueda M; Ohshima T; Fujita K; Rikimaru K; Takahashi N; Enomoto S; Tsuchida N
Oncogene; 1989 Apr; 4(4):499-505. PubMed ID: 2654810
[TBL] [Abstract][Full Text] [Related]
12. Alterations of mouse proto-oncogenes in sarcomas induced after transplantation of human tumors in athymic nude mice.
Yuasa Y; Yamazaki H; Maruo K; Ueyama Y; Shibuya M; Tamaoki N
Jpn J Cancer Res; 1990 Apr; 81(4):333-9. PubMed ID: 2114387
[TBL] [Abstract][Full Text] [Related]
13. Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP.
Nag A; Smith RG
Prostate; 1989; 15(2):115-22. PubMed ID: 2678039
[TBL] [Abstract][Full Text] [Related]
14. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
15. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
16. Activation of a human c-K-ras oncogene.
Yamamoto F; Perucho M
Nucleic Acids Res; 1984 Dec; 12(23):8873-85. PubMed ID: 6096811
[TBL] [Abstract][Full Text] [Related]
17. Activation of N-ras in a human melanoma cell line.
Padua RA; Barrass NC; Currie GA
Mol Cell Biol; 1985 Mar; 5(3):582-5. PubMed ID: 3887133
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
19. Transformation of NIH3T3 cells with synthetic c-Ha-ras genes.
Kamiya H; Miura K; Ohtomo N; Koda T; Kakinuma M; Nishimura S; Ohtsuka E
Jpn J Cancer Res; 1989 Mar; 80(3):200-3. PubMed ID: 2542206
[TBL] [Abstract][Full Text] [Related]
20. The ras gene family and human carcinogenesis.
Bos JL
Mutat Res; 1988 May; 195(3):255-71. PubMed ID: 3283542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
